✦ LIBER ✦

Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation

✍ Scribed by Toor, A A; Choo, S Y; Little, J A

Book ID: 110012662
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 79 KB
Volume: 26
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702490

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of splenectomy on engraftmen

The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation

✍ Meera Banaji; Scott I. Bearman; C. Dean Buckner; Reginald A. Clift; William I. B 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Comparison of allogeneic stem cell trans

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as

Excellent disease eradication by myeloab

Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia

✍ H. T. Greinix; H. Loidolt; W. Rabitsch; A. Schulenburg; F. Keil; M. Mitterbauer; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 118 KB

Acute bleeding complications in patients

Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 × 109 and 20 × 109 per L

✍ Shoshan Nevo; Alice K. Fuller; Eric Hartley; Mark E. Borinsky; Georgia B. Vogels 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Continuous infusion idarubicin and oral

Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation

✍ Ferrara, F; Palmieri, S; Annunziata, M; Viola, A; Pocali, B; Califano, C; D'Arco 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Analysis of remobilization success in pa

Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost

✍ Boeve, S; Strupeck, J; Creech, S; Stiff, P J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB